Table 2.

LncRNAs that modulate the response of neuroblastoma to chemotherapy.

LncRNA	Sample	Cell line	Target/pathway	Function	Kaplan Meier	Ref
NORAD	Human, Mouse	SK-N-SH, IMR-32, SK-N-SH/DOx, IMR-32/Dox	ATG5, LC3-I/II, P62, Beclin-1, PCNA, Cyclin-D1 Bcl-2, Bax, HDAC8	NORAD by upregulating HDAC8 via buffering miR-144-3p could enhance doxorubicin resistance of NB.	Higher expression of NORAD was associated with a lower OS rate.	(53)
SNHG7	Human	HUVEC, LAN-6, SK-N-AS, LAN-6/Cis, SK-N-AS/Cis	miR-329-3p, MYO10, LC3B-I/II, Beclin-1, P62	SNHG7 by regulating the miR-329-3p/MYO10 axis could enhance chemoresistance to cisplatin via modulating cisplatin-induced autophagy.	–	(62)
SNHG16	Human, Mouse	SK-N-AS, SK-N-SH, SK-N-AS/Cis, SK-N-SH/Cis	miR-338-3p, PLK4 MRP-1, p-gp, P13K/AKT	SNHG16 via regulating miR-338-3p/PLK4 axis could enhance cisplatin resistance in NB.	–	(63)